Invention Grant
- Patent Title: Predicting risk of major adverse cardiac events
- Patent Title (中): 预测主要不良心脏事件的风险
-
Application No.: US12425956Application Date: 2009-04-17
-
Publication No.: US08090562B2Publication Date: 2012-01-03
- Inventor: James V. Snider , Eugene R. Heyman
- Applicant: James V. Snider , Eugene R. Heyman
- Applicant Address: US NY New York
- Assignee: Critical Care Diagnostics, Inc.
- Current Assignee: Critical Care Diagnostics, Inc.
- Current Assignee Address: US NY New York
- Agency: Fish & Richardson P.C.
- Main IPC: G06G7/58
- IPC: G06G7/58
Abstract:
Measurement of circulating ST2 and natriuretic peptide (e.g., NT-proBNP) concentrations is useful for the prognostic evaluation of subjects, in particular for the prediction of adverse clinical outcomes, e.g., mortality, transplantation, and heart failure.
Public/Granted literature
- US20090264779A1 PREDICTING RISK OF MAJOR ADVERSE CARDIAC EVENTS Public/Granted day:2009-10-22
Information query
